Heard yesterday--talk about Medivation takeover at CNBC half time.The guest expert said, BMRN and ARIA--Biomarin and Ariad based on her information.The half time panel said,MDVN according to the options.
This CNBC Half time happened after ONXX bid. The panel was speculating about next candidate for acquisition in biotech. Not Pump-- as acquisition game is tough to guess.
The expert on M&A saw high activity in BMRN and ARIA-- I own none.Should I ?